Top Markets
#1 Islamic Coin Islamic Coin +152.23%
#2 Bitway Bitway +48.15%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +38.47%
#4 Starpower Starpower +34.30%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.46%
#6 Pons Pons +21.04%
#7 aelf aelf +19.67%
#8 Pleasing Gold Pleasing Gold +17.80%
#9 Venom Venom +14.89%
#10 Decred Decred +14.18%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Argenica Therapeutics Ltd Argenica Therapeutics Ltd

Argenica Therapeutics Ltd

AGN
Clasificación en acciones #29930
Argenica Therapeutics Limited, a biotechnology company, engages in the research... Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia.
Precio por acción
$0.14810981
Capitalización bursátil
$19.03M
Cambio (1 día)
2.44%
Cambio (1 año)
-67.22%
País
AU
Comercio Argenica Therapeutics Ltd (AGN)

Categoría

Healthcare
Ratio P/S de Argenica Therapeutics Ltd (AGN)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Argenica Therapeutics Ltd, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Argenica Therapeutics Ltd desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR